News
Post-transplant diet: Gruel no longer rules
New findings from Italy: Anti-bacterial diet, long the scourge of stem-cell transplant patients, doesn’t lower risk of infection.
News
For minorities with PE: Less advanced treatment, more mortality
Asians/Pacific Islanders with pulmonary embolism faced the lowest risk of hospitalization but died at the highest rate, new study finds.
News
High cost and demand for old cancer drug sparks crisis
Experts have voiced alarm at the scarcity and cost of fludarabine, an old drug deemed crucial to cellular therapy for leukemia.
News
‘Modest’ benefit for lecanemab in Alzheimer’s disease, but adverse events are common
The Food and Drug Administration is expected to make a decision about possible approval of the drug in January 2023.
News
Atezolizumab fails to improve outcomes in postsurgery kidney cancer
Study authors call for greater attention to patient selection for RCC adjuvant immunotherapy.
News
Chronic hepatitis B infections associated with a range of liver malignancies
Treatment with nucleos(t)ide analogues lowers risk of extrahepatic cancer in patients with hepatitis B infections.
News
Previous breast cancer doesn’t increase poor outcomes in pregnancy, study finds
Mothers with cancer diagnoses were more likely to undergo cesarean section, however.
News
Hormone therapy–depression link may depend on mode of administration
Registry study suggests different effects from local and systemic types of hormone therapy plus age.
News
Post Roe, pregnant SCD patients facing “dire” risks
Doctors warn that lost abortion rights put many pregnant patients with sickle cell disease (SCD) in danger.
News
Fertility physicians say they lack access to miscarriage drugs
Even before Dobbs, few offered mifepristone/misoprostol to patients with early pregnancy loss, small survey suggests.
News
HPV-positive women who undergo IVF don’t have worse outcomes
They were more likely than counterparts to get pregnant and have live births, new study finds.
News
Gloom lifting as MCL treatments evolve
A rare blood cancer remains incurable, yet new therapies have yielded improved prognoses and survival rates.